Recombinant CD39 / ENTPD1 (Marker of Tumor-specific T cells) Antibody, IgG2a, Clone: [r22A9], Mouse, Monoclonal

Artikelnummer: NBT-953-MSM7-P1ABX
Artikelname: Recombinant CD39 / ENTPD1 (Marker of Tumor-specific T cells) Antibody, IgG2a, Clone: [r22A9], Mouse, Monoclonal
Artikelnummer: NBT-953-MSM7-P1ABX
Hersteller Artikelnummer: 953-MSM7-P1ABX
Alternativnummer: NBT-953-MSM7-P1ABX-100
Hersteller: NeoBiotechnologies
Wirt: Mouse
Kategorie: Antikörper
Applikation: IHC
Spezies Reaktivität: Human
Immunogen: Prokaryotic recombinant protein corresponding to a portion of the external domain of the CD39 molecule
Alternative Synonym: ATPDase, DKFZp686D194, DKFZp686I093, Ecto apyrase, Ecto ATP diphosphohydrolase, Ectonucleoside triphosphate diphosphohydrolase 1, ENTPD1, FLJ40921, FLJ40959, Lymphoid cell activation antigen, NTPDase 1, SPG64
CD39 is a transmembrane glycoprotein and an extracellular nucleotide-hydrolyzing enzyme that plays a key role in regulating extracellular ATP and ADP levels. Also known as E-type apyrase, CD39 hydrolyzes ATP and ADP to AMP, which is further converted to adenosine. By degrading ADP, CD39 inhibits platelet aggregation, contributing to its anti-thrombotic function and potential use in preventing coronary artery occlusion and thrombotic stroke. Intracellularly, CD39 undergoes glycosylation at six N-glycosylation sites before translocating to the membrane to become an active enzyme. Alternative splicing gives rise to three isoforms: vascular, placenta I, and placenta II, with variations at the N-terminus and C-terminus. CD39 is expressed in vascular tissues, including the placenta, lung, skeletal muscle, and kidney, as well as on endothelial cells, smooth muscle cells, cardiac cells, and platelets. In the immune system, CD39 is present on activated B cells, a subset of activated T cells, activated NK cells, macrophages, dendritic cells, and Langerhans cells. It is not expressed on resting lymphocytes but is found in lymphoid tissues, particularly in the mantle zone and paracortical lymphocytes. CD39-expressing cells may provide protection to lymphocytes from the toxic effects of ATP released from damaged cells. Originally identified on Epstein-Barr virus-transformed B cells, CD39 is now recognized as a key immunoregulatory enzyme involved in inflammation, immune suppression, and thrombotic balance.
Klonalität: Monoclonal
Klon-Bezeichnung: [r22A9]
Molekulargewicht: 70-100 kDa
Isotyp: IgG2a
NCBI: 953
UniProt: P49961
Formulierung: 200ug/ml of Ab produced in CHO cell mammalian-based expression system. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
SDS-PAGE Analysis of Purified Recombinant CD39 Mouse Monoclonal Antibody (r22A9). Confirmation of Purity and Integrity of Antibody.
Formalin-fixed, paraffin-embedded human placenta stained with CD39 Recombinant Mouse Monoclonal Antibody (r22A9). Inset: PBS instead of primary antibody, secondary only negative control.